Heart Test Laboratories Stock Performance
| HSCS Stock | USD 3.00 0.06 2.04% |
The company retains a Market Volatility (i.e., Beta) of 0.18, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Heart Test's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heart Test is expected to be smaller as well. At this point, Heart Test Laboratories has a negative expected return of -0.34%. Please make sure to check out Heart Test's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if Heart Test Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 2.21 | Five Day Return (5.66) | Year To Date Return (19.79) | Ten Year Return (98.24) | All Time Return (98.24) |
Last Split Factor 1:100 | Last Split Date 2024-05-17 |
1 | Financial Review Advanced BioMedical Technologies Heart Test Laboratories | 01/14/2025 |
2 | Acquisition by Andrew Simpson of 45000 shares of Heart Test at 3.33 subject to Rule 16b-3 | 01/16/2025 |
3 | Disposition of 23216 shares by Andrew Simpson of Heart Test at 6.59 subject to Rule 16b-3 | 02/06/2025 |
4 | Discretionary transaction by Mark Hilz of tradable shares of Heart Test subject to Rule 16b-3 | 03/11/2025 |
| Begin Period Cash Flow | 1.7 M |
Heart |
Heart Test Relative Risk vs. Return Landscape
If you would invest 385.00 in Heart Test Laboratories on December 17, 2024 and sell it today you would lose (85.00) from holding Heart Test Laboratories or give up 22.08% of portfolio value over 90 days. Heart Test Laboratories is currently does not generate positive expected returns and assumes 4.0111% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Heart, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Heart Test Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heart Test's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heart Test Laboratories, and traders can use it to determine the average amount a Heart Test's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0838
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HSCS |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Heart Test is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heart Test by adding Heart Test to a well-diversified portfolio.
Heart Test Fundamentals Growth
Heart Stock prices reflect investors' perceptions of the future prospects and financial health of Heart Test, and Heart Test fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heart Stock performance.
| Return On Equity | -6.44 | ||||
| Return On Asset | -0.92 | ||||
| Operating Margin | (507.88) % | ||||
| Current Valuation | 1.73 M | ||||
| Shares Outstanding | 980.32 K | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 195.73 X | ||||
| Revenue | 18.6 K | ||||
| Gross Profit | 10.14 K | ||||
| EBITDA | (6.16 M) | ||||
| Net Income | (6.61 M) | ||||
| Cash And Equivalents | 4.27 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.04 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 10.81 X | ||||
| Cash Flow From Operations | (6.07 M) | ||||
| Earnings Per Share | 5.35 X | ||||
| Market Capitalization | 2.88 M | ||||
| Total Asset | 9.5 M | ||||
| Retained Earnings | (67.36 M) | ||||
| Working Capital | 5.6 M | ||||
About Heart Test Performance
Assessing Heart Test's fundamental ratios provides investors with valuable insights into Heart Test's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Heart Test is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 34 K | 30.3 K | |
| Return On Tangible Assets | (0.96) | (1.01) | |
| Return On Capital Employed | (0.73) | (0.77) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (1.04) | (1.09) |
Things to note about Heart Test Laboratories performance evaluation
Checking the ongoing alerts about Heart Test for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heart Test Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heart Test generated a negative expected return over the last 90 days | |
| Heart Test has high historical volatility and very poor performance | |
| Heart Test has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 10.14 K. | |
| Heart Test Laboratories currently holds about 4.27 M in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Heart Test has a poor financial position based on the latest SEC disclosures |
- Analyzing Heart Test's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heart Test's stock is overvalued or undervalued compared to its peers.
- Examining Heart Test's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heart Test's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heart Test's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heart Test's stock. These opinions can provide insight into Heart Test's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.